D-1607-2014 Class II Terminated

Recalled by Alvogen, Inc — Pine Brook, NJ

FDA drug recall D-1607-2014 was initiated by Alvogen, Inc on Aug 28, 2014 and is designated Class II. Reason for recall: Failed Content Uniformity Specifications - The lot failed to meet the acceptance criteria for Uniformity of Dosage Units at the time of release for the oxycodone component. The recall status is terminated (terminated Apr 30, 2015). Affected quantity: 8,964 (100 Count) bottles.

Recall details

Product Type
Drugs
Report Date
Oct 1, 2014
Initiation Date
Aug 28, 2014
Termination Date
Apr 30, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8,964 (100 Count) bottles

Product description

Oxycodone and Acetaminophen Tablets USP 10 mg/325 mg 100 count bottles Rx Only. Manufactured by Norwich Pharmaceuticals Inc., Norwich, NY 13185 USA; Distributed by Alvogen Inc, Pine Brook NJ 07058 USA.

Reason for recall

Failed Content Uniformity Specifications - The lot failed to meet the acceptance criteria for Uniformity of Dosage Units at the time of release for the oxycodone component.

Distribution pattern

Nationwide

Code information

NDC #47781-0230-01; Lot # 453289; Exp 08/31/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1607-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1607-2014. Report a data issue: hello@regdatalab.com.